FDA Announces “Proactive” Approach To Rx-To-OTC Switches
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to take a more active role in initiating Rx-to OTC switches in coming years, Senior Associate Commissioner for Management & Systems Jeff Weber said Feb. 3
You may also be interested in...
FDA Budget Increases For OTC Drugs, Supplements Survive 2004 Process
Funding increases for OTC drug and dietary supplement activities at FDA are likely to see increased support from the Bush administration and Congress as the fiscal year 2005 budget process kicks off
OTC Pricing Pressures Will Grow As Uninsured Self-Medicate – Consultant
OTC drugs will play a larger role in the healthcare debate as prescription drug prices continue to rise, according to Kay Holcombe, VP for Washington, D.C.-based consulting firm Policy Directions
FDA OTC Funding Increase For ’04 Trimmed By House Appropriations Cmte.
Funding for FDA nonprescription drug activities would increase $700,000 under the FY 2004 Agriculture Appropriations bill reported out of the House Appropriations Committee June 25